201 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
21 Recruiting A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Conditions: Hypertriglyceridemia;   Mixed Hyperlipidemia
Interventions: Drug: TRIA-662;   Drug: Placebo
22 Not yet recruiting MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Conditions: Diabetes;   Hyperlipidemia;   Hypertension;   Cardiovascular Disease
Intervention: Behavioral: CVRS Intervention
23 Not yet recruiting Improving Heart Health in Appalachia
Conditions: Obesity;   Hypertension;   Hyperlipidemia;   Depression
Interventions: Behavioral: patient-centered, culturally appropriate, self-care CVD risk reduction;   Other: Referral to primary care provider for CVD risk management
24 Recruiting Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
Conditions: Nephrotic Syndrome;   Hyperlipidemia
Intervention: Drug: Pravastatin
25 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
26 Unknown  Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Condition: Hyperlipidemia
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin
27 Unknown  The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians
Conditions: Hypertension;   Hyperlipidemia
Intervention: Behavioral: Free Generic Samples (hydrochlorothiazide, simvastatin)
28 Recruiting Pilot Study Testing Feasibility of Health Screening at Farm Site
Conditions: Diabetes Screening;   Hyperlipidemia Screening;   Hypertension Screening
Intervention: Other: Worksite screening for DM, HTN and hyperlipidemia
29 Recruiting to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
Condition: HbA1c Level Associated With Lipid Compositions
Interventions: Drug: Pitavastatin calcium 4mg;   Drug: Pitavastatin calcium 2mg
30 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
31 Unknown  Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin;   Drug: Statin plus fenofibrate;   Drug: Statin plus niacin ER/laropiprant
32 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
Condition: Hyperlipidemia
Interventions: Drug: Atorvastatin10mg, Ezetimibe10mg;   Drug: Atorvastatin10mg, Ezetimibe placebo;   Drug: Atorvastatin20mg, Ezetimibe10mg;   Drug: Atorvastatin20mg, Ezetimibe placebo;   Drug: Atorvastatin40mg, Ezetimibe10mg;   Drug: Atorvastatin40mg, Ezetimibe placebo
33 Not yet recruiting Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
Conditions: Diabetes;   Hyperlipidemia
Interventions: Drug: JLP-1310, Fasted followed by fed;   Drug: JLP-1310, Fed followed by fasted
34 Recruiting Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Condition: Hyperlipidemia
Intervention: Drug: Atorvastatin
35 Not yet recruiting Rosuvastatin Adherence App Study in China
Conditions: Dyslipidemia;   Hyperlipidemia
Interventions: Other: Smart phone based patient support tool;   Other: Control application: only for data collection
36 Recruiting Safety for 24 Weeks Intake of Korean Red Ginseng in Adults
Conditions: Healthy;   Diabetes;   Hypertension;   Hyperlipidemia
Interventions: Dietary Supplement: Korean Red Ginseng;   Dietary Supplement: Placebo
37 Recruiting Acute Microvascular Changes With LDL Apheresis
Condition: Hyperlipidemia
Intervention: Procedure: Plasmapharesis
38 Recruiting Patient and Provider Assessment of Lipid Management Registry
Conditions: Hyperlipidemia;   Hypercholesterolemia;   Cardiovascular Disease;   Diabetes;   Chronic Kidney Disease (CKD);   Hypertension;   Smoking;   Myocardial Infarction (MI);   Unstable Angina;   Angina;   Coronary Artery Disease (CAD);   Stroke;   Transient Ischemic Attack (TIA);   Carotid Stenosis;   Peripheral Arterial Disease;   Atherosclerosis;   Claudication
Intervention:
39 Recruiting Comparison of LDL Particle Count With Other Available Lipid Tests
Condition: Hyperlipidemia
Intervention:
40 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years